Treehouse Eyes Partners with Johnson & Johnson Vision to Provide ACUVUE Abiliti

Treehouse Eyes and Johnson & Johnson Vision have partnered to give patients access to ACUVUE Abiliti Overnight Therapeutic Lenses for myopia management in collaboration with select practices in cities across the U.S., while also increasing myopia

Treehouse Eyes Partners with Johnson & Johnson Vision to Provide ACUVUE Abiliti
December 09, 2021
AcuFocus Receives Approvable Letter From FDA for IC-8 Small Aperture IOL

AcuFocus announced that it has received an Approvable Letter from the FDA for its IC-8 small aperture IOL, which is designed for cataract patients.

AcuFocus Receives Approvable Letter From FDA for IC-8 Small Aperture IOL
December 08, 2021
New Myopia Management Social Media Campaign Is About To Be Launched By The Global Myopia Awareness Coalition (GMAC)

The Global Myopia Awareness Coalition (GMAC), formed in early 2019, is composed of leading ophthalmic companies and eye health associations that agree on a clear need for greater public awareness about myopia in children.

New Myopia Management Social Media Campaign Is About To Be Launched By The Global Myopia Awareness Coalition (GMAC)
December 08, 2021
Amydis Completes Pre-IND Meeting with FDA for Development of First-in-Class Retinal Tracer for Diagnosis of ALS

Amydis announced the successful completion of a pre-IND (investigational new drug) meeting with the FDA regarding the development plans for a small-molecule tracer to detect TDP43 in the retina of amyotrophic lateral sclerosis (ALS) patients.

Amydis Completes Pre-IND Meeting with FDA for Development of First-in-Class Retinal Tracer for Diagnosis of ALS
December 07, 2021
New Study: Cataract Surgery Lowers The Risk of Dementia, Alzheimer’s Disease

Cataracts affect most older adults at risk for dementia, and new research shows that cataract surgery is linked to a lower risk of dementia.

New Study: Cataract Surgery Lowers The Risk of Dementia, Alzheimer’s Disease
December 07, 2021
€3 Million EU Project HyVIS to Develop Bionic Synapses for Retinal Prostheses

HyVIS, the European project coordinated by the IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology), is ready to begin.

€3 Million EU Project HyVIS to Develop Bionic Synapses for Retinal Prostheses
December 06, 2021
Bionic Eye Study Paves the Way Towards Human Trials

In a three-month study, a bionic eye developed by a team of biomedical researchers from the University of Sydney and UNSW proved to be safe and stable for long-term implantation, paving the way for human trials.

Bionic Eye Study Paves the Way Towards Human Trials
December 03, 2021
Ophthalmic Sciences Unveils World’s First AI Contactless Device For Measuring IOP

Israeli company Ophthalmic Sciences has unveiled the IOPerfect, which the company describes as the world's first AI-based contactless IOP measuring device.

Ophthalmic Sciences Unveils World’s First AI Contactless Device For Measuring IOP
December 03, 2021
Omeros to Sell OMIDRIA® Franchise to Rayner in a Deal Worth More Than $1 Billion

Omeros Corporation announced today that it has entered a definitive deal with Rayner Surgical Group Limited to sell OMIDRIA.

Omeros to Sell OMIDRIA® Franchise to Rayner in a Deal Worth More Than $1 Billion
December 03, 2021
Nicox Announces Positive Post Hoc Results from its Clinical Trial for Dry Eye Treatment

Nicox SA revealed positive post-hoc data from its Mississippi Phase 2b clinical trial, finding that once-daily dosed NCX 4251, fluticasone propionate ophthalmic suspension 0.1%, is beneficial in alleviating dry eye symptoms in a subgroup of patients.

Nicox Announces Positive Post Hoc Results from its Clinical Trial for Dry Eye Treatment
December 02, 2021
Daha fazla